Filing Flows › NeuroPace (NPCE) › Q2 2026 › vs Q2 2025
NeuroPace (NPCE) Q2 2026 vs Q2 2025 (year over year)
NeuroPace's revenue rose $3.3M (+17%) from $19.5M in Q2 2025 to $22.8M in Q2 2026.
NeuroPace, Q2 2026: revenue $22.8M (+17% year over year), operating margin -22.5%, net loss $6.2M, operating cash flow −$3.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $22.8M | $19.5M | $3.3M | +17% |
| Net loss | $6.2M | $8.7M | −$2.5M | -28% |
| Costs & expenses | $29.0M | $28.2M | $874K | +3% |
| Operating costs | $28.0M | $27.7M | $279K | +1% |
| Interest & other, net | $1.1M | $462K | $595K | +129% |
| Cost of revenue | $3.9M | $3.3M | $632K | +19% |
| Research & development | $6.9M | $6.8M | $53K | +0.8% |
| Sales & marketing | $12.1M | $11.5M | $635K | +6% |
| General & admin | $5.0M | $6.1M | −$1.0M | -17% |
| Operating cash sources | $6.3M | $5.4M | $892K | +16% |
| Depreciation | $100K | $100K | $0 | 0% |
| Share-based compensation | $2.3M | $3.2M | −$925K | -29% |
| Cash used in operations | $3.9M | $2.1M | $1.8M | +87% |
| Net loss absorbed | $6.2M | $8.7M | −$2.5M | -28% |
| Working capital & other | $106K | −$3.2M | $3.3M | — |
Questions
How much did NeuroPace's revenue grow year over year in Q2 2026?
NeuroPace's revenue rose $3.3M (+17%) from $19.5M in Q2 2025 to $22.8M in Q2 2026.